KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortization of Goodwill Amortization of Goodwill Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Beginning Cash Balance Beginning Cash Balance Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt repayments

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Cost of Revenue EBIAT Gross Profit Leases Long-Term Debt Issuances Long-Term Debt Repayments Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Net Shares Issued Shares Outstanding Shares Outstanding Shares Repurchased Short-Term Debt repayments

Nu Skin Enterprises (NUS) Long-Term Debt Issuances (2016 - 2026)

Nu Skin Enterprises' Long-Term Debt Issuances history spans 14 years, with the latest figure at $40.0 million for Q3 2025.

On a quarterly basis, Long-Term Debt Issuances rose 166.67% to $40.0 million in Q3 2025 year-over-year; TTM through Dec 2025 was $55.0 million, a 266.67% increase, with the full-year FY2025 number at $55.0 million, up 266.67% from a year prior.
Long-Term Debt Issuances hit $40.0 million in Q3 2025 for Nu Skin Enterprises, up from $15.0 million in the prior quarter.
Over the last five years, Long-Term Debt Issuances for NUS hit a ceiling of $460.0 million in Q2 2022 and a floor of $15.0 million in Q3 2024.
Historically, Long-Term Debt Issuances has averaged $97.5 million across 5 years, with a median of $50.0 million in 2021.
Biggest five-year swings in Long-Term Debt Issuances: skyrocketed 666.67% in 2022 and later crashed 80.43% in 2023.
Tracing NUS's Long-Term Debt Issuances over 5 years: stood at $25.0 million in 2021, then surged by 1740.0% to $460.0 million in 2022, then crashed by 80.43% to $90.0 million in 2023, then plummeted by 83.33% to $15.0 million in 2024, then skyrocketed by 166.67% to $40.0 million in 2025.
Business Quant data shows Long-Term Debt Issuances for NUS at $40.0 million in Q3 2025, $15.0 million in Q3 2024, and $90.0 million in Q2 2023.